My view

The price of needed meds

And the hidden loophole costing Pennsylvania patients thousands

By JENNIFER RILEY
Posted 8/5/25

For the 7.7 million Pennsylvanians managing chronic conditions, prescription medications aren’t a luxury; they’re a necessity. But for many, even with insurance, the cost of staying on …

This item is available in full to subscribers.

Please log in to continue

Log in
My view

The price of needed meds

And the hidden loophole costing Pennsylvania patients thousands

Posted

For the 7.7 million Pennsylvanians managing chronic conditions, prescription medications aren’t a luxury; they’re a necessity. But for many, even with insurance, the cost of staying on treatment can feel overwhelming. That’s where co-pay assistance programs come in.

These assistance programs, offered by manufacturers, were created to help patients afford medicine their doctor prescribed. But now, insurers and pharmacy benefit managers (PBMs) are manipulating that help through something called “copay adjustment programs,” which include “copay accumulators” and “copay maximizers.” 

These programs may sound technical, but their impact is painfully clear: they stop co-pay assistance from counting toward a patient’s deductible or out-of-pocket maximum. That means the assistance gets used up and patients are left holding the bill.

Let’s break it down. A patient in Honesdale living with cystic fibrosis might receive a manufacturer co-pay card to help cover their specialty medication. They use the card at the pharmacy, assuming they’re chipping away at their deductible. But unbeknownst to them, their insurer is running a copay accumulator program. When the assistance runs out, the insurer demands thousands more before coverage actually kicks in.

It’s deceptive. It’s unfair. And it’s happening every day across our commonwealth.

National data shows the scale of the problem. Research shows more than 83 percent of commercial insurance enrollees are in plans with copay accumulator programs, and 73 percent are in plans using maximizers. These are not rare exceptions. They’re the norm.

What’s worse, the savings from these programs don’t go back to patients. They go to insurers and PBMs. Meanwhile, adherence to medication drops, chronic conditions worsen, and emergency care costs rise. It’s a short-term gain for payers and a long-term crisis for patients and the health system.

Some states are taking action. At least 21 states have enacted laws to limit or ban these practices, ensuring that co-pay assistance actually helps reduce patients’ financial burden. Sadly, Pennsylvania is not one of them.

That needs to change.

I hear from people across our state—parents skipping their own medication to pay for their child’s, seniors shocked by bills they thought were covered, and working families blindsided by insurance fine print. These aren’t edge cases. They’re our neighbors.

If Pennsylvania is serious about protecting patients, we need to ensure co-pay assistance counts toward patients’ deductibles and out-of-pocket maximums. We need transparency, accountability and a commitment to ensuring patients come first, not profit margins.

Jennifer Riley is the statewide executive director of Patients Come First Pennsylvania and is spearheading its mission of ensuring Pennsylvania’s patients receive timely access to innovative health care. Readers can follow the effort on Facebook and X @PatientsFirstPA, and visit the website for more information at www.patientscomefirst.com

Pennsylvanians, price, meds, my view, loophole

Comments

No comments on this item Please log in to comment by clicking here